Background: Kenya is faced with an increasing challenge of co-morbid psychological and social factors among HIV-Infected patients which has had a profound impact on their medication adherence. A major psychosocial factor that is a barrier in adherence is depression associated with HIV. This study aimed at measuring the effect of depression on participants’ own reported adherence to antiretroviral therapy. Objectives: To determine the impact depression has had on adherence to antiretroviral therapy among HIV-infected patients at a Kenyatta Hospital. Methodology: A cross-sectional study design was carried out at Kenyatta National Hospital, Nairobi, Kenya. Three hundred and eighty four (384) HIV infected participants were assessed for HIV rela...
This study investigated factors of adherence to Antiretroviral Treatment (ART), factors or variables...
Background: Published research on depression among people living with HIV/AIDS (PLWHA) from Africa i...
BACKGROUND:As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle ...
Aim: To determine the influence of depression on adherence to antiretroviral (ARV) therapy among HIV...
Background: Depressive disorders are associated with poorer health outcomes in people living with hu...
Background: Adherence to antiretroviral therapy is a necessity for the attainment of favorable treat...
ImportanceDepression is a common co-morbidity for people living with HIV (PLWH) and is associated wi...
Aim. To determine changes in adherence to antiretroviral therapy (ART) in HIV-positive patients with...
Background: Studies have identified several programmatic and nonprogrammatic indicators that affect ...
ImportanceDepression is a common co-morbidity for people living with HIV (PLWH) and is associated wi...
Background. Depression is consistently associated with increased risk of Human Immunodeficiency Viru...
Background: Combination antiretroviral therapy (ART) is the cornerstone of management of patients wi...
Background: Studies have identified several programmatic and nonprogrammatic indicators that affect ...
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle...
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle...
This study investigated factors of adherence to Antiretroviral Treatment (ART), factors or variables...
Background: Published research on depression among people living with HIV/AIDS (PLWHA) from Africa i...
BACKGROUND:As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle ...
Aim: To determine the influence of depression on adherence to antiretroviral (ARV) therapy among HIV...
Background: Depressive disorders are associated with poorer health outcomes in people living with hu...
Background: Adherence to antiretroviral therapy is a necessity for the attainment of favorable treat...
ImportanceDepression is a common co-morbidity for people living with HIV (PLWH) and is associated wi...
Aim. To determine changes in adherence to antiretroviral therapy (ART) in HIV-positive patients with...
Background: Studies have identified several programmatic and nonprogrammatic indicators that affect ...
ImportanceDepression is a common co-morbidity for people living with HIV (PLWH) and is associated wi...
Background. Depression is consistently associated with increased risk of Human Immunodeficiency Viru...
Background: Combination antiretroviral therapy (ART) is the cornerstone of management of patients wi...
Background: Studies have identified several programmatic and nonprogrammatic indicators that affect ...
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle...
Background: As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle...
This study investigated factors of adherence to Antiretroviral Treatment (ART), factors or variables...
Background: Published research on depression among people living with HIV/AIDS (PLWHA) from Africa i...
BACKGROUND:As antiretroviral therapy (ART) for HIV becomes increasingly available in low and middle ...